연구성과로 돌아가기

2023 연구자 정보 (1076 / 1135)

※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
Author Name 제1저자 여부 교신저자 여부 Address ResearcherID ORCID Paper Title WoS Edition 최상위 JCR(%) WoS Category Related Email
Ng, Matthew C. H.
(Ng, MCH)
DukeNUS Duke Univ, Natl Canc Ctr Singapore, Natl Univ Singapore, Sch Med, Singapore, Singapore

[JCR상위 74.7] Circulating Tumor DNA as a Predictive Biomarker for Clinical Outcomes With Margetuximab and Pembrolizumab in Pretreated HER2-Positive Gastric/Gastroesophageal Adenocarcinoma SCIE 74.7 ONCOLOGY ykkang@amc.seoul.kr;
Odegaard, Justin I.
(Odegaard, JI)
Guardant Hlth, Redwood City, CA USA

[JCR상위 74.7] Circulating Tumor DNA as a Predictive Biomarker for Clinical Outcomes With Margetuximab and Pembrolizumab in Pretreated HER2-Positive Gastric/Gastroesophageal Adenocarcinoma SCIE 74.7 ONCOLOGY ykkang@amc.seoul.kr;
Paik, Yong-Han
(Paik, YH)
Sungkyunkwan Univ, Samsung Med Ctr, Dept Med, Sch Med, Seoul, South Korea

[JCR상위 74.7] Radiotherapy trend in elderly hepatocellular carcinoma: retrospective analysis of patients diagnosed between 2005 and 2017 ESCI 74.7 ONCOLOGY hee.ro.park@samsung.com;
Park, Hee Chul
(Park, HC)
교신저자 Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Radiat Oncol, Seoul, South Korea
Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Radiat Oncol, 81 Irwon Ro, Seoul 06351, South Korea


[JCR상위 74.7] Radiotherapy trend in elderly hepatocellular carcinoma: retrospective analysis of patients diagnosed between 2005 and 2017 ESCI 74.7 ONCOLOGY hee.ro.park@samsung.com;
Park, Jongmoo
(Park, J)
제1저자 Kyungpook Natl Univ, Sch Med, Dept Radiat Oncol, Daegu, South Korea
Kyungpook Natl Univ, Dept Radiat Oncol, Chilgok Hosp, Sch Med, Daegu, South Korea


[JCR상위 74.7] Comparison between 1-week and 2-week palliative radiotherapy courses for superior vena cava syndrome
[JCR상위 68.0] Free Vertical Latissimus Dorsi Flap for Tongue Reconstruction After Total Glossectomy
[JCR상위 81.5] Influence of respiratory movement during post mastectomy radiotherapy on targets and heart for breast cancer
[JCR상위 1.5] Korean Real-World Data on Patients With Unresectable Stage III NSCLC Treated With Durvalumab After Chemoradiotherapy: PACIFIC-KR
ESCI
SCIE
1.5 ONCOLOGY
MEDICINE, RESEARCH & EXPERIMENTAL
ONCOLOGY;RESPIRATORY SYSTEM
jelee@knu.ac.kr;
leejspo@knu.ac.kr;
hi_juji@daum.net;
droij@jnu.ac.kr;
Park, Soo-Jin
(Park, SJ)
Daegu Haany Univ, Coll Korean Med, Dept Histol & Anat, Gyongsan, South Korea
Daegu Haany Univ, Coll Korean Med, Daegu 38610, South Korea


[JCR상위 74.7] Comparative Pharmacokinetic Profiles of a Novel Low-Dose Micronized Formulation of Raloxifene 45 mg (AD-101) and the Conventional Raloxifene 60 mg in Healthy Subjects
[JCR상위 83.5] Fed and fasted bioequivalence assessment of two formulations of extended-release fixed-dose combination dapagliflozin/metformin (10/1,000 mg) tablets in healthy subjects
SCIE
ESCI
74.7 PHARMACOLOGY & PHARMACY yry@knu.ac.kr;
yry@knu.ac.kr;wintersj@knu.ac.kr;
Rosales, Minori Koshiji
(Rosales, MK)
MacroGenics, Rockville, MD USA
Sesen Bio, Cambridge, MA USA


[JCR상위 74.7] Circulating Tumor DNA as a Predictive Biomarker for Clinical Outcomes With Margetuximab and Pembrolizumab in Pretreated HER2-Positive Gastric/Gastroesophageal Adenocarcinoma SCIE 74.7 ONCOLOGY ykkang@amc.seoul.kr;
Song, Eun-Kee
(Song, EK)
Jeonbuk Natl Univ, Med Sch, Jeonju, South Korea

[JCR상위 74.7] Circulating Tumor DNA as a Predictive Biomarker for Clinical Outcomes With Margetuximab and Pembrolizumab in Pretreated HER2-Positive Gastric/Gastroesophageal Adenocarcinoma SCIE 74.7 ONCOLOGY ykkang@amc.seoul.kr;
Sun, Jichao
(Sun, JC)
MacroGenics, Rockville, MD USA

[JCR상위 74.7] Circulating Tumor DNA as a Predictive Biomarker for Clinical Outcomes With Margetuximab and Pembrolizumab in Pretreated HER2-Positive Gastric/Gastroesophageal Adenocarcinoma SCIE 74.7 ONCOLOGY ykkang@amc.seoul.kr;
Sym, Sun Jin
(Sym, SJ)
Gachon Univ, Gil Med Ctr, Incheon, South Korea

[JCR상위 74.7] Circulating Tumor DNA as a Predictive Biomarker for Clinical Outcomes With Margetuximab and Pembrolizumab in Pretreated HER2-Positive Gastric/Gastroesophageal Adenocarcinoma SCIE 74.7 ONCOLOGY ykkang@amc.seoul.kr;
Uronis, Hope E.
(Uronis, HE)
Duke Univ, Med Ctr, Durham, NC USA

[JCR상위 74.7] Circulating Tumor DNA as a Predictive Biomarker for Clinical Outcomes With Margetuximab and Pembrolizumab in Pretreated HER2-Positive Gastric/Gastroesophageal Adenocarcinoma SCIE 74.7 ONCOLOGY ykkang@amc.seoul.kr;
Yen, Jennifer
(Yen, J)
Guardant Hlth, Redwood City, CA USA

[JCR상위 74.7] Circulating Tumor DNA as a Predictive Biomarker for Clinical Outcomes With Margetuximab and Pembrolizumab in Pretreated HER2-Positive Gastric/Gastroesophageal Adenocarcinoma SCIE 74.7 ONCOLOGY ykkang@amc.seoul.kr;
Yu, Jeong Il
(Yu, JI)
Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Radiat Oncol, Seoul, South Korea
Sungkyunkwan Univ, Sch Med, Dept Radiat Oncol, Samsung Med Ctr, Seoul, South Korea
MTC-0984-2025
Yu, Jeong Il

[JCR상위 74.7] Radiotherapy trend in elderly hepatocellular carcinoma: retrospective analysis of patients diagnosed between 2005 and 2017
[JCR상위 34.6] Korean Practice Guidelines for Gastric Cancer 2022: An Evidence-based, Multidisciplinary Approach
[JCR상위 34.6] Korean Practice Guidelines for Gastric Cancer 2022: An Evidence-based, Multidisciplinary Approach (vol 23, pg 3, 2023)
ESCI
SCIE
34.6 ONCOLOGY
GASTROENTEROLOGY & HEPATOLOGY;ONCOLOGY
hee.ro.park@samsung.com;
hyesukhan@chungbuk.ac.kr;nam20131114@gmail.com;seongho.kong@snu.ac.kr;
Bu, Hee Hyung
(Bu, HH)
제1저자 교신저자 Kyungpook Natl Univ, Sch Comp Sci & Engn, Daegu, South Korea
0000-0003-1637-6523
BU, HEE HYUNG
[JCR상위 74.9] Content-based image retrieval using a fusion of global and local features SCIE 74.9 ENGINEERING, ELECTRICAL & ELECTRONIC;TELECOMMUNICATIONS hhbu@knu.ac.kr;
Cui, Shenghui
(Cui, SH)
Seoul Natl Univ, Dept Elect & Comp Engn, Seoul, South Korea

[JCR상위 74.9] Improved dynamics of DC bus control with a zig-zag transformer for bipolar DC distribution systems SCIE 74.9 ENGINEERING, ELECTRICAL & ELECTRONIC jj.jung@knu.ac.kr;
페이지 이동: